122 related articles for article (PubMed ID: 33450)
1. [Bucco-linquo-facial and choriform hyperkinesies (author's transl)].
Trillet M; Laurent B
Sem Hop; 1978 Nov 8-15; 54(37-40):1159-63. PubMed ID: 33450
[TBL] [Abstract][Full Text] [Related]
2. [Senile dyskinesias and tardive dyskinesias].
Brion S; Plas J; Chevalier JF; Dussaux P
Encephale; 1988 Sep; 14 Spec No():215-9. PubMed ID: 2905649
[TBL] [Abstract][Full Text] [Related]
3. [Neuroleptic-induced movement disorders: historical perspectives].
Wolf MA; Yassa R; Llorca PM
Encephale; 1993; 19(6):657-61. PubMed ID: 12404786
[TBL] [Abstract][Full Text] [Related]
4. [Abnormal involuntary movements in the elderly and their treatment (author's transl)].
Delwaide PJ; Desseilles M
Sem Hop; 1978 Nov 18-25; 54(41-42):1247-9. PubMed ID: 32624
[TBL] [Abstract][Full Text] [Related]
5. [Clinical aspects of tardive dyskinesias induced by neuroleptics].
Villeneuve A; Lajeunesse C
Encephale; 1988 Sep; 14 Spec No():209-14. PubMed ID: 2905648
[TBL] [Abstract][Full Text] [Related]
6. [Controlled therapeutic study of spontaneous bucco-linguo-facial dyskinesias (author's transl)].
Delwaide PJ; Desseilles M
Sem Hop; 1979 Oct 18-25; 55(35-36):1585-9. PubMed ID: 44015
[TBL] [Abstract][Full Text] [Related]
7. Recognition and diagnosis of tardive dyskinesia.
Klawans HL
J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):3-7. PubMed ID: 2858477
[TBL] [Abstract][Full Text] [Related]
8. Parallels between neuroleptic effects and lethargic encephalitis: the production of dyskinesias and cognitive disorders.
Breggin PR
Brain Cogn; 1993 Sep; 23(1):8-27. PubMed ID: 8105824
[TBL] [Abstract][Full Text] [Related]
9. [Tardive dyskinesia. A possible complication of chronic treatment with neuroleptics].
D'Aquila F; Rampello L
Riv Neurol; 1990; 60(4):140-5. PubMed ID: 1982720
[TBL] [Abstract][Full Text] [Related]
10. [Orofacial dyskinesia. A current pathology].
Gaillard-Perera H; Gaillard A
Rev Stomatol Chir Maxillofac; 1992; 93(5):327-32. PubMed ID: 1411232
[TBL] [Abstract][Full Text] [Related]
11. [Oral dyskinesis, facial dystonia].
Nakamura S; Akiguchi I
Nihon Rinsho; 1993 Nov; 51(11):2978-82. PubMed ID: 8277580
[TBL] [Abstract][Full Text] [Related]
12. [Tardive dyskinesia induced by neuroleptics. A review of the literature].
Diepart E; Cottereau MJ; Deniker P
Encephale; 1979; 5(4):317-37. PubMed ID: 42528
[TBL] [Abstract][Full Text] [Related]
13. Movement disorders with neuroleptic drug treatment.
Tarsy D
Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742
[TBL] [Abstract][Full Text] [Related]
14. [Tardive dyskinesia].
Sabbatini F; Gentile S; De Mattei M; Pinessi L; Rainero I
Minerva Med; 1985 Apr; 76(16):797-802. PubMed ID: 2860619
[TBL] [Abstract][Full Text] [Related]
15. Involuntary movement disorders--each has a meaning all its own.
Kramer J; Klawans HL
Geriatrics; 1979 Sep; 34(9):63-71. PubMed ID: 38189
[TBL] [Abstract][Full Text] [Related]
16. Historical perspective on movement disorders.
Friedman JH
J Clin Psychiatry; 2004; 65 Suppl 9():3-8. PubMed ID: 15189105
[TBL] [Abstract][Full Text] [Related]
17. Facial dyskinesias.
Kaufman DM
Psychosomatics; 1989; 30(3):263-9. PubMed ID: 2669010
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of dyskinesias with tiapride (author's transl)].
Kocher R; Hobi V
Sem Hop; 1980 Dec 18-25; 56(47-68):2033-4. PubMed ID: 6109379
[TBL] [Abstract][Full Text] [Related]
19. A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: implications for future strategies in treatment.
Crossman AR
Mov Disord; 1990; 5(2):100-8. PubMed ID: 1970120
[TBL] [Abstract][Full Text] [Related]
20. Animal models of tardive dyskinesia.
Kulkarni SK; Dhir A
Int Rev Neurobiol; 2011; 98():265-87. PubMed ID: 21907091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
